Cargando…

Measuring force of infection and vaccine effects on transmission stages in clinical trials of experimental malaria vaccines

Detalles Bibliográficos
Autores principales:	Felger, Ingrid, Genton, Blaise, Beck, Hans-Peter, Smith, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472333/ http://dx.doi.org/10.1186/1475-2875-11-S1-O50

Ejemplares similares

Molecular epidemiology of force of infection in malaria
por: Felger, Ingrid, et al.
Publicado: (2010)

Predicted impact of mosquito-stage transmission-blocking vaccines using an ensemble of microsimulations
por: Di Pasquale, Aurelio, et al.
Publicado: (2010)

Towards a multi-antigen multi-stage malaria vaccine
por: Hill, Adrian VS, et al.
Publicado: (2014)

Malaria vaccines for eradication
por: Alonso, Pedro
Publicado: (2012)

Measuring malaria transmission reduction en route to elimination
por: Steketee, Richard W
Publicado: (2014)

Modeling the effects of vector control interventions in reducing malaria transmission, morbidity and mortality
por: Chitnis, Nakul, et al.
Publicado: (2010)

Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technology
por: Ballif, Marie, et al.
Publicado: (2010)

Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies
por: Mugittu, Kefas, et al.
Publicado: (2005)

The role of LCCL proteins in malaria transmission
por: Saeed, Sadia, et al.
Publicado: (2010)

Viral vectored transmission blocking vaccines against Plasmodium falciparum
por: Kapulu, Melissa C, et al.
Publicado: (2010)

Dynamics of P. vivax clones in a cohort of children with or without primaquine treatment at baseline
por: Wampfler, Rahel, et al.
Publicado: (2014)

Plasmodium vivax in Papua New Guinea: high diversity and gene flow among endemic populations signal roadblocks for elimination
por: Koepfli, Cristian, et al.
Publicado: (2012)

Controlled human malaria infection in Kenyan adults: A safe model that could accelerate assessment of novel drugs and vaccines in malaria endemic populations
por: Hodgson, Susanne, et al.
Publicado: (2014)

Any progress for HIV vaccines to come?
por: Wigzell, Hans
Publicado: (2006)

Plant-produced transmission blocking Plasmodium falciparum Pfs25 subunit and VLP based vaccine candidates
por: Musivchuk, Konstantin, et al.
Publicado: (2012)

Impact of protective haemoglobins C and S on P. falciparum malaria transmission in endemic area
por: Gouagna, Louis C, et al.
Publicado: (2010)

Rapid mapping of seasonal malaria transmission risk for strategic elimination planning in Swaziland
por: Cohen, Justin M, et al.
Publicado: (2012)

Adaptive clinical trials of three PfSPZ products for development of a whole sporozoite vaccine that prevents Plasmodium falciparum infection, disease and transmission
por: Hoffman, Stephen L
Publicado: (2012)

A review of malaria vaccine clinical projects based on the WHO rainbow table
por: Schwartz, Lauren, et al.
Publicado: (2012)

Knowledge/attitude/practices of HPV & cervical cancer, willingness to participate in vaccine trial in preparation for HIV & HPV vaccine trials in Mali
por: Poole, D, et al.
Publicado: (2012)

Age-shifting in malaria incidence upon cessation of interventions: a simulation study
por: Pemberton-Ross, Peter, et al.
Publicado: (2014)

Progress with PfSPZ Vaccine, a radiation attenuated Plasmodium falciparum sporozoite vaccine
por: Billingsley, Peter, et al.
Publicado: (2014)

Interaction between iron/folic acid and malaria
por: Kraemer, Klaus, et al.
Publicado: (2012)

Male circumcision as a preventive measure limiting HIV transmission
por: Quinn, Thomas C
Publicado: (2006)

Extended malaria parasite clearance time in African children following artemisinin-combination therapy enhances transmission to Anopheles mosquitoes
por: Beshir, Khalid B, et al.
Publicado: (2012)

HPV vaccines in Brazil and the world
por: Villa, Luisa
Publicado: (2014)

Are investments in malaria control saving the lives of children? Challenges in using all-cause child mortality for measuring the impact of malaria control programs
por: Eisele, Thomas
Publicado: (2014)

Complete abrogation of sporozoite-induced sterile immunity by blood stage parasites of homologous and heterologous malaria species
por: Inoue, Megumi, et al.
Publicado: (2010)

Comparison of detection methods to estimate asexual Plasmodium falciparum parasite prevalence and gametocyte carriage in a community survey in Tanzania
por: Mwingira, Felista, et al.
Publicado: (2014)

Non-neutralizing antibodies and vaccine-induced protection
por: Demberg, Thorsten, et al.
Publicado: (2006)

Elite control of HIV infection: implications for vaccines
por: Pereyra, Florencia, et al.
Publicado: (2006)

Peptides reloaded - new strategies for tolerogenic vaccination
por: Hamann, Alf, et al.
Publicado: (2011)

Genetic determinants of hepatitis B vaccine response
por: Png, Eileen, et al.
Publicado: (2011)

Vaccine-elicited systemic and mucosal humoral responses of lactating rhesus monkeys vaccinated with the transmitted/founder HIV Envelope 1086C
por: Fouda, G, et al.
Publicado: (2012)

Comparison of a frequentist and Bayesian response-adaptive randomisation approach in multi-stage phase II selection trials with multiple experimental arms
por: Yap, Christina, et al.
Publicado: (2015)

Significant protection from infection and AIDS progression after gastrointestinal and oral vaccinations, respectively, with a SIV DNA/rMVA vaccine
por: Aldovini, A, et al.
Publicado: (2012)

OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial
por: de Souza, MS, et al.
Publicado: (2009)

Cell Biological Characterization of the Malaria Vaccine Candidate Trophozoite Exported Protein 1
por: Kulangara, Caroline, et al.
Publicado: (2012)

Immune complexes can dampen inflammatory signaling at the mucosal surface during protective SIV vaccination
por: Smith, AJ, et al.
Publicado: (2012)

Toward a glycopeptide-based HIV-1 vaccine
por: Wang, Lai-Xi, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_o98brnafgbls6bc5o3v6cubcfa